IP Verse

Stabilization Of Vaccines By Lyophilization - EP2851087

The patent EP2851087 was granted to Sanofi Pasteur Biologics on Jun 18, 2025. The application was originally filed on Nov 7, 2007 under application number EP14180710A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2851087

SANOFI PASTEUR BIOLOGICS
Application Number
EP14180710A
Filing Date
Nov 7, 2007
Status
Patent Maintained As Amended
May 16, 2025
Grant Date
Jun 18, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DILGJan 19, 2018MAIWALDADMISSIBLE

Patent Citations (28) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5173418
DESCRIPTIONUS6184024
DESCRIPTIONUS6497884
DESCRIPTIONUS6589531
DESCRIPTIONUS6676936
DESCRIPTIONUS6696281
DESCRIPTIONUS7115270
DESCRIPTIONWO0139802
DESCRIPTIONWO02072835
DESCRIPTIONWO02102828
DESCRIPTIONWO03060088
DESCRIPTIONWO03103571
DESCRIPTIONWO2004045529
DESCRIPTIONWO2005055957
DESCRIPTIONWO2005082020
DESCRIPTIONWO2006044857
DESCRIPTIONWO2006116182
DESCRIPTIONWO9837911
OPPOSITIONEP0130619
OPPOSITIONUS2005255121
OPPOSITIONUS4500512
OPPOSITIONUS6284277
OPPOSITIONWO0029024
OPPOSITIONWO2005066333
OPPOSITIONWO2008057550
OPPOSITIONWO9510601
SEARCHWO03048184
SEARCHWO03060088

Non-Patent Literature (NPL) Citations (32) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AMBERG ET AL., J. VIROL., (1999), vol. 73, pages 8083 - 8094-
DESCRIPTION- ARROYO ET AL., J. VIROL., (2004), vol. 78, pages 12497 - 12507-
DESCRIPTION- ARROYO ET AL., TRENDS MOL. MED., (2001), vol. 7, pages 350 - 354-
DESCRIPTION- BURKE; MONATH, Fields Virology, (2001), pages 1043 - 1126-
DESCRIPTION- CHAMBERS ET AL., J. VIROL., (1999), vol. 73, pages 3095 - 3101-
DESCRIPTION- DOS SANTOS ET AL., VIRUS RES., (1995), vol. 35, pages 35 - 41-
DESCRIPTION- "Flaviviridae", RICE, Virology, RAVEN-LIPPINCOTT, (1995), vol. I, page 937-
DESCRIPTION- GALLER ET AL., VACCINE, (1998), vol. 16, no. 9/10, pages 1024 - 1028-
DESCRIPTION- GUIRAKHOO ET AL., J. VIROL., (2000), vol. 74, pages 5477 - 5485-
DESCRIPTION- GUIRAKHOO ET AL., J. VIROL., (2004), vol. 78, pages 4761 - 4775-
DESCRIPTION- GUIRAKHOO ET AL., J. VIROL., (2004), vol. 78, pages 9998 - 10008-
DESCRIPTION- GUIRAKHOO ET AL., VIROLOGY, (1999), vol. 257, pages 363 - 372-
DESCRIPTION- MONATH ET AL., J. INFECT. DIS., (2003), vol. 188, pages 1213 - 1230-
DESCRIPTION- MONATH ET AL., VACCINE, (1999), vol. 17, pages 1869 - 1882-
DESCRIPTION- PUGACHEV ET AL., AM. J. TROP. MED. HYG., (2004), vol. 71, pages 639 - 645-
DESCRIPTION- PUGACHEV ET AL., New Generation Vaccines, MARCEL DEKKER, (2004), pages 559 - 571-
DESCRIPTION- RICE ET AL., NEW BIOLOGIST, (1989), vol. 1, pages 285 - 296-
DESCRIPTION- RICE ET AL., SCIENCE, (1985), vol. 229, pages 726 - 733-
DESCRIPTION- SMITHBURN ET AL., Yellow Fever Vaccination, WORLD HEALTH ORG., (1956), page 238-
DESCRIPTION- "Tick-borne Encephalitis", GRESIKOVA ET AL., The Arboviruses, Ecology and Epidemiology, CRC PRESS, (1988), vol. IV, pages 177 - 203-
DESCRIPTION- YASUMURA ET AL., NIHON RINSHO, (1963), vol. 21, pages 1201 - 1215-
DESCRIPTION- "Yellow Fever", MONATH, Vaccines, SAUNDERS, (1999), pages 815 - 879-
OPPOSITION- "75 065: Stamaril®", Rote Liste Service Gmbh, ROTE LISTE® 2004 : Arzneimittelverzeichnis für Deutschland (einschliesslich EU-Zulassungen und bestimmter Medizinprodukte; [ROTE LISTE], EDITIO VERLAG, AULENDORF, DE, (20040000), page 2pp, 75, XP055457245-
OPPOSITION- "75 078 Stamaril®", Rote Liste Service Gmbh, Rote Liste 1998, EDITIO VERLAG, AULENDORF/WÜRTT., (19980000), page 2pp, 75, XP055457251-
OPPOSITION- GlaxoSmithKline GmbH & Co. KG, "Varilrix® Fachinformation", (20010700), pages 1 - 2, XP055457262-
OPPOSITION- GlaxoSmithKline Inc.,, "Product monograph Priorix®", (20060519), pages 1 - 16, XP055457267-
OPPOSITION- LUECKEL B; ET AL, "EFFECTS OF FORMULATION AND PROCESS VARIABLES ON THE AGGREGATION OF FREEZE-DRIED INTERLEUKIN-6 (IL-6) AFTER LYOPHILIZATION AND ON STORAGE", PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY,, (19980000), vol. 3, no. 3, pages 337 - 346, XP000938724-
OPPOSITION- CLELAND et al., "A SPECIFIC MOLAR RATIO OF STABILIZER TO PROTEIN IS REQUIRED FOR STORAGE STABILITY OF A LYOPHILIZED MONOCLONAL ANTIBODY", Journal of Pharmaceutical Sciences,, (20000000), vol. 90, no. 3, pages 310 - 321, XP001179875
OPPOSITION- Anas Al-Hussein, Henning Gieseler, "The Effect of Mannitol Crystallization in Mannitol-Sucrose systems on LDH Stability during Freeze-Drying", Journal of Pharmaceutical Sciences, (20120700), vol. 101, no. 7, pages 2534 - 2544, XP055457275
OPPOSITION- YU L., "AMORPHOUS PHARMACEUTICAL SOLIDS: PREPARATION, CHARACTERIZATION AND STABILIZATION", Advanced Drug Delivery Rev,, (20010000), vol. 48, no. 1, pages 27 - 42, XP009065056
OPPOSITION- Alexandra I Kim; Michael J Akers; Steven L Nail, "The Physical State of Mannitol after Freeze-Drying: Effects of Mannitol Concentration, Freezing Rate, and a Noncrystallizing Cosolute", Journal of Pharmaceutical Sciences,, (19980801), vol. 87, no. 8, pages 931 - 935, XP055248890
SEARCH- ECKELS KENNETH H ET AL, "Modification of dengue virus strains by passage in primary dog kidney cells: Preparation of candidate vaccines and immunization of monkeys.", AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (200312), vol. 69, no. 6 Supplement, ISSN 0002-9637, pages 12 - 16, XP007912230 [X] 1,3,11,14-15 * page 13, column l; tables 1-3 * [I] 4-10,13 [A] 2,12-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents